Logo image of FCUV

FOCUS UNIVERSAL INC (FCUV) Stock Fundamental Analysis

NASDAQ:FCUV - Nasdaq - US34417J2033 - Common Stock - Currency: USD

4.72  +0.52 (+12.38%)

Fundamental Rating

3

FCUV gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 124 industry peers in the Electronic Equipment, Instruments & Components industry. FCUV has a great financial health rating, but its profitability evaluates not so good. FCUV does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

FCUV had negative earnings in the past year.
FCUV had a negative operating cash flow in the past year.
FCUV had negative earnings in each of the past 5 years.
In the past 5 years FCUV always reported negative operating cash flow.
FCUV Yearly Net Income VS EBIT VS OCF VS FCFFCUV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2M -4M -6M

1.2 Ratios

FCUV's Return On Assets of -110.67% is on the low side compared to the rest of the industry. FCUV is outperformed by 93.55% of its industry peers.
FCUV has a Return On Equity of -141.33%. This is amonst the worse of the industry: FCUV underperforms 85.48% of its industry peers.
Industry RankSector Rank
ROA -110.67%
ROE -141.33%
ROIC N/A
ROA(3y)-73.26%
ROA(5y)-57.64%
ROE(3y)-98.92%
ROE(5y)-74.84%
ROIC(3y)N/A
ROIC(5y)N/A
FCUV Yearly ROA, ROE, ROICFCUV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K -4K

1.3 Margins

Looking at the Gross Margin, with a value of 1.62%, FCUV is doing worse than 89.52% of the companies in the same industry.
FCUV's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for FCUV so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 1.62%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-50.39%
GM growth 5Y-20.79%
FCUV Yearly Profit, Operating, Gross MarginsFCUV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K

9

2. Health

2.1 Basic Checks

FCUV does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, FCUV has more shares outstanding
FCUV has less shares outstanding than it did 5 years ago.
There is no outstanding debt for FCUV. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
FCUV Yearly Shares OutstandingFCUV Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
FCUV Yearly Total Debt VS Total AssetsFCUV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M

2.2 Solvency

FCUV has an Altman-Z score of 6.34. This indicates that FCUV is financially healthy and has little risk of bankruptcy at the moment.
FCUV has a Altman-Z score of 6.34. This is amongst the best in the industry. FCUV outperforms 83.87% of its industry peers.
There is no outstanding debt for FCUV. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 6.34
ROIC/WACCN/A
WACC8.92%
FCUV Yearly LT Debt VS Equity VS FCFFCUV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M

2.3 Liquidity

FCUV has a Current Ratio of 4.39. This indicates that FCUV is financially healthy and has no problem in meeting its short term obligations.
FCUV has a Current ratio of 4.39. This is in the better half of the industry: FCUV outperforms 77.42% of its industry peers.
FCUV has a Quick Ratio of 4.24. This indicates that FCUV is financially healthy and has no problem in meeting its short term obligations.
FCUV's Quick ratio of 4.24 is amongst the best of the industry. FCUV outperforms 83.87% of its industry peers.
Industry RankSector Rank
Current Ratio 4.39
Quick Ratio 4.24
FCUV Yearly Current Assets VS Current LiabilitesFCUV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

0

3. Growth

3.1 Past

FCUV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -712.42%.
The Revenue for FCUV has decreased by -41.80% in the past year. This is quite bad
The Revenue for FCUV have been decreasing by -22.89% on average. This is quite bad
EPS 1Y (TTM)-712.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-980.24%
Revenue 1Y (TTM)-41.8%
Revenue growth 3Y-34.7%
Revenue growth 5Y-22.89%
Sales Q2Q%-52.82%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
FCUV Yearly Revenue VS EstimatesFCUV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for FCUV. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
FCUV Price Earnings VS Forward Price EarningsFCUV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
FCUV Per share dataFCUV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 -0.4 -0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

FCUV does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

FOCUS UNIVERSAL INC

NASDAQ:FCUV (4/24/2025, 6:10:55 PM)

4.72

+0.52 (+12.38%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)02-28 2025-02-28
Earnings (Next)05-13 2025-05-13
Inst Owners3.13%
Inst Owner Change0%
Ins Owners50.2%
Ins Owner Change0%
Market Cap33.56M
Analysts0
Price TargetN/A
Short Float %N/A
Short Ratio0.02
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 54.36
P/FCF N/A
P/OCF N/A
P/B 10.5
P/tB 10.5
EV/EBITDA N/A
EPS(TTM)-0.65
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.66
FCFYN/A
OCF(TTM)-0.65
OCFYN/A
SpS0.09
BVpS0.45
TBVpS0.45
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -110.67%
ROE -141.33%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 1.62%
FCFM N/A
ROA(3y)-73.26%
ROA(5y)-57.64%
ROE(3y)-98.92%
ROE(5y)-74.84%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-50.39%
GM growth 5Y-20.79%
F-Score3
Asset Turnover0.15
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 25.41%
Cap/Sales 3.03%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.39
Quick Ratio 4.24
Altman-Z 6.34
F-Score3
WACC8.92%
ROIC/WACCN/A
Cap/Depr(3y)20.4%
Cap/Depr(5y)14.74%
Cap/Sales(3y)6.93%
Cap/Sales(5y)4.44%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-712.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-980.24%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-41.8%
Revenue growth 3Y-34.7%
Revenue growth 5Y-22.89%
Sales Q2Q%-52.82%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-51.6%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-31.72%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-31.97%
OCF growth 3YN/A
OCF growth 5YN/A